CLINICAL AND LABORATORY STUDIES OF 1,25-DIHYDROXYCHOLECALCIFEROL IN MYELOFIBROSIS

被引:11
作者
MCKINLEY, R
KWAN, YL
FORD, D
LAMPOTANG, PRL
MASON, RS
MANOHARAN, A
机构
[1] ROYAL N SHORE HOSP,DEPT ENDOCRINOL,ST LEONARDS,SYDNEY,AUSTRALIA
[2] ST GEORGE HOSP,DEPT HAEMATOL,KOGARAH,SYDNEY,AUSTRALIA
关键词
D O I
10.1111/j.1365-2141.1987.tb02281.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:252 / 254
页数:3
相关论文
共 6 条
[1]  
ARLET P, 1984, LANCET, V1, P1013
[2]  
FREAKE HC, 1984, CANCER RES, V44, P3627
[3]   MYELOID PROGENITOR CELLS IN THE CIRCULATION OF PATIENTS WITH MYELOFIBROSIS AND OTHER MYELOPROLIFERATIVE DISORDERS [J].
HIBBIN, JA ;
NJOKU, OS ;
MATUTES, E ;
LEWIS, SM ;
GOLDMAN, JM .
BRITISH JOURNAL OF HAEMATOLOGY, 1984, 57 (03) :495-503
[4]  
MCCARTHY DM, 1984, LANCET, V1, P78
[5]  
MESSNER HA, 1982, J CELL PHYSL S, V1, P45
[6]   THE USEFULNESS OF 1,25-DIHYDROXY-VITAMIN-D3 (1,25(OH)2VIT-D3) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSIS [J].
RICHARD, C ;
MAZORRA, F ;
IRIONDO, A ;
MAZO, E ;
BELLO, C ;
ZUBIZARRETA, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 62 (02) :399-400